Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer

被引：0
|
作者：
Yuichi Takiguchi
Shunichiro Iwasawa
Koichi Minato
Yosuke Miura
Akihiko Gemma
Rintaro Noro
Kozo Yoshimori
Masato Shingyoji
Mitsunori Hino
Masahiro Ando
Hiroaki Okamoto
机构：
[1] Chiba University,Department of Medical Oncology, Graduate School of Medicine
[2] Gunma Prefectural Cancer Center,Department of Respiratory Medicine
[3] Nippon Medical School,Department of Pulmonary Medicine and Oncology, Graduate School of Medicine
[4] Anti-tuberculosis Association Fukujuji Hospital,Department of Respiratory Medicine
[5] Chiba Cancer Center,Department of Thoracic Disease
[6] Nippon Medical School Chiba Hokusoh Hospital,Respiratory Disease Center, INBAHITEC Medical Center
[7] Tsuboi Cancer Center Hospital,Division of Cancer Chemotherapy
[8] Yokohama Municipal Citizen’s Hospital,Department of Respiratory Medicine and Medical Oncology
来源：
International Journal of Clinical Oncology | 2015年 / 20卷
关键词：
Non-squamous; Non-small cell lung carcinoma; Bevacizumab; Docetaxel; Carboplatin; Phase II study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：659 / 667
页数：8
相关论文
共 50 条
  • [1] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer
    Takiguchi, Yuichi
    Iwasawa, Shunichiro
    Minato, Koichi
    Miura, Yosuke
    Gemma, Akihiko
    Noro, Rintaro
    Yoshimori, Kozo
    Shingyoji, Masato
    Hino, Mitsunori
    Ando, Masahiro
    Okamoto, Hiroaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 659 - 667
  • [2] Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-na⟨ve advanced non-squamous non-small cell lung cancer with EGFR mutations
    Tamiya, Motohiro
    Tamiya, Akihiro
    Shiroyama, Takayuki
    Takeoka, Sawa
    Naito, Yujiro
    Omachi, Naoki
    Kimura, Yohei
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Atagi, Shinji
    Hirashima, Tomonori
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 608 - 614
  • [3] Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations
    Motohiro Tamiya
    Akihiro Tamiya
    Takayuki Shiroyama
    Sawa Takeoka
    Yujiro Naito
    Naoki Omachi
    Yohei Kimura
    Naoko Morishita
    Hidekazu Suzuki
    Norio Okamoto
    Kyoichi Okishio
    Tomoya Kawaguchi
    Shinji Atagi
    Tomonori Hirashima
    [J]. Investigational New Drugs, 2018, 36 : 608 - 614
  • [4] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [5] Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study
    Masato Karayama
    Naoki Inui
    Shigeki Kuroishi
    Koshi Yokomura
    Mikio Toyoshima
    Toshihiro Shirai
    Masafumi Masuda
    Takashi Yamada
    Kazumasa Yasuda
    Takafumi Suda
    Kingo Chida
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 445 - 452
  • [6] Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-na⟨ve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study
    Karayama, Masato
    Inui, Naoki
    Kuroishi, Shigeki
    Yokomura, Koshi
    Toyoshima, Mikio
    Shirai, Toshihiro
    Masuda, Masafumi
    Yamada, Takashi
    Yasuda, Kazumasa
    Suda, Takafumi
    Chida, Kingo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 445 - 452
  • [7] Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
    Jones, Benjamin S.
    Jerome, Mary S.
    Miley, Deborah
    Jackson, Bradford E.
    DeShazo, Mollie R.
    Reddy, Vishnu V. B.
    Singh, Karan P.
    Brown, Olivia C.
    Robert, Francisco
    [J]. LUNG CANCER, 2017, 106 : 125 - 130
  • [8] A phase II first line study of gemcitabine, carboplatin and bevacizumab in advanced stage non-squamous non-small cell lung cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhami
    San Pedro-Salcedo, Melanie
    Wakelee, Heather
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S674 - S674
  • [9] Phase II study of the 1st line chemotherapy consisting of bevacizumab, docetaxel and carboplatin for patients with non-squamous non-small cell lung cancer: TCOG1001
    Minato, K.
    Gemma, A.
    Shingyoji, M.
    Yoshimori, K.
    Kuribayashi, H.
    Okamoto, H.
    Ando, M.
    Takiguchi, Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S823 - S823
  • [10] PHASE II TRIAL OF BEVACIZUMAB PLUS DOCETAXEL IN PATIENTS WITH PREVIOUSLY TREATED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Ohyanagi, F.
    Kudo, K.
    Yanagitani, N.
    Horiike, A.
    Horai, T.
    Nishio, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 441 - 442
12345